Malaria prophylaxis policy for travellers from Europe to the Indian Sub Continent
2006

Malaria Prevention for European Travelers to the Indian Subcontinent

Commentary Evidence: moderate

Author Information

Author(s): Behrens RH, Bisoffi Z, Björkman A, Gascon J, Hatz C, Jelinek T, Legros F, Mühlberger N, Voltersvik P

Primary Institution: Hospital for Tropical Diseases & London School of Hygiene & Tropical Medicine, London, UK

Hypothesis

Is the use of chemoprophylaxis necessary for travelers from Europe to the Indian Subcontinent?

Conclusion

The study suggests that the recommendation for non-selective prescribing of malaria chemoprophylaxis for travelers to India, Pakistan, Bangladesh, and Sri Lanka should be dropped.

Supporting Evidence

  • The proportion of malaria cases from the Indian Subcontinent in 2004 was between 1.4% and 4.6% of total imported cases.
  • Imported malaria cases reported from the ISC have been declining.
  • Most travelers to the ISC are not using chemoprophylaxis despite the risk of malaria.

Takeaway

The study found that many travelers to India and nearby countries don't need malaria pills because the risk of getting malaria is very low.

Methodology

Analysis of malaria cases reported from the Indian Subcontinent to eight European countries between 1999 and 2004.

Potential Biases

Potential bias in reporting and data collection methods across different countries.

Limitations

The study relies on reported cases, which may not capture all instances of malaria.

Participant Demographics

UK residents traveling to the Indian Subcontinent.

Statistical Information

Confidence Interval

95% CI 27–46

Digital Object Identifier (DOI)

10.1186/1475-2875-5-7

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication